DM

DMIIR

Drugs Made In America Acquisition II Corp. - Right

NASDAQ
Market Cap
P/E Ratio
57.99
Dividend Yield
3.99%
Volume
52W High
52W Low
Avg Volume
52W Range

Financial Statements

What does this mean?

Income statement, balance sheet, and cash flow over time

Metric
No financial data available

Institutional Ownership

What does this mean?

Top institutions holding DMIIR

Institution Shares Held Value Date
Vanguard Group 150,000,000 $25,000,000,000 Nov 2025
BlackRock 140,000,000 $23,500,000,000 Nov 2025
State Street 80,000,000 $13,500,000,000 Oct 2025
Fidelity 65,000,000 $11,000,000,000 Nov 2025
Geode Capital 35,000,000 $5,900,000,000 Sep 2025

Top ETFs holding DMIIR

ETF Weight Shares
QQQ 8.50% 14,820,459
VGT 6.20% 24,922,106
SPY 4.50% 43,806,801
IVV 4.20% 6,646,604
VOO 3.80% 29,600,937

Frequently Asked Questions

Common questions about DMIIR

Drugs Made In America Acquisition II Corp. - Right (DMIIR) is a publicly traded company listed on NASDAQ. Drugs Made In America Acquisition II Corp. - Right (DMIIR) is included in the Stock Monitor database for research and watchlists.

The current stock price of DMIIR is $104.99, with a change of -0.01% in the latest session. Stock prices are updated during market hours and may be delayed.

Yes, DMIIR pays dividends with a current dividend yield of 3.99%. Dividend payments are typically made quarterly, though the exact schedule varies. Check the dividend calendar for upcoming ex-dividend dates.

The P/E (Price-to-Earnings) ratio of DMIIR is 57.99. This relatively high P/E may indicate growth expectations or that the stock is trading at a premium. The P/E ratio compares the stock price to earnings per share and is commonly used for valuation.

DMIIR has a market capitalization of $800.00 billion, making it a mega-cap company. Market cap is calculated by multiplying the current stock price by the total number of outstanding shares.

The 52-week trading range for DMIIR is $89.14 (low) to $157.38 (high). This range represents the lowest and highest prices the stock has traded at over the past year.

Trade

Buy/Sell via broker links (affiliate).

Trading 212
Open Broker
Links may be affiliate links. Trading involves risk.

Paper Trade

Save a buy/sell to your portfolio tracker (not a real trade).

Sign in to save trades to your portfolio tracker.

Paper Orders

Limit/stop reminders, with optional bracket (take profit + stop loss).

Sign in to place paper orders.

Price Alerts

Notify when DMIIR crosses your target.

Sign in to create alerts and sync them across devices.

About

Drugs Made In America Acquisition II Corp. - Right (DMIIR) is included in the Stock Monitor database for research and watchlists.

CEO
N/A
Employees
110,999
IPO Date
Jan 1, 2000

Analyst Ratings

What does this mean?
Morgan Stanley
Dec 11, 2025
Overweight
JPMorgan
Nov 24, 2025
Buy
Bernstein
Nov 7, 2025
Buy
Piper Sandler
Oct 21, 2025
Buy
Goldman Sachs
Sep 29, 2025
Hold
Price Target
$130.19